Piyasa Haberleri

En güncel finans ve ekonomi haberlerini, piyasa gelişmelerini, raporları ve analizleri PipVero’da takip edin.

Kaynak: Newsfile Corp Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
ROSEN, REGARDED INVESTOR COUNSEL, Encourages PennyMac Financial Services, Inc. Investors to Inquire About Securities Class Action Investigation - PFSI

ROSEN, REGARDED INVESTOR COUNSEL, Encourages PennyMac Financial Services, Inc. Investors to Inquire About Securities Class Action Investigation - PFSI

New York, New York--(Newsfile Corp. - August 6, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of PennyMac Financial Services, Inc. (NYSE: PFSI) resulting from allegations that PennyMac may have issued materially misleading business information to the investing public. SO WHAT: If you purchased PennyMac securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

İlgili Semboller 1
PFSI PFSI
Kaynak: Newsfile Corp
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: Newsfile Corp Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Elauwit Connection, Inc. Investors to Inquire About Securities Class Action Investigation - ELWT

ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Elauwit Connection, Inc. Investors to Inquire About Securities Class Action Investigation - ELWT

New York, New York--(Newsfile Corp. - August 6, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Elauwit Connection, Inc. (NASDAQ: ELWT) resulting from allegations that Elauwit may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Elauwit securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

İlgili Semboller 1
ELWT ELWT
Kaynak: Newsfile Corp
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: Zacks Investment Research Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
ICU Medical (ICUI) Tops Q2 Earnings and Revenue Estimates

ICU Medical (ICUI) Tops Q2 Earnings and Revenue Estimates

ICU Medical (ICUI) came out with quarterly earnings of $2.37 per share, beating the Zacks Consensus Estimate of $1.91 per share. This compares to earnings of $2.1 per share a year ago.

İlgili Semboller 1
ICUI ICUI
Kaynak: Zacks Investment Research
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: Zacks Investment Research Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Onto Innovation (ONTO) Q2 Earnings and Revenues Beat Estimates

Onto Innovation (ONTO) Q2 Earnings and Revenues Beat Estimates

Onto Innovation (ONTO) came out with quarterly earnings of $1.93 per share, beating the Zacks Consensus Estimate of $1.68 per share. This compares to earnings of $1.25 per share a year ago.

İlgili Semboller 1
ONTO ONTO
Kaynak: Zacks Investment Research
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: Zacks Investment Research Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Morgan Stanley Direct Lending Fund (MSDL) Surpasses Q2 Earnings and Revenue Estimates

Morgan Stanley Direct Lending Fund (MSDL) Surpasses Q2 Earnings and Revenue Estimates

Morgan Stanley Direct Lending Fund (MSDL) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.5 per share a year ago.

İlgili Semboller 1
MSDL MSDL
Kaynak: Zacks Investment Research
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: Zacks Investment Research Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Mach Natural Resources LP (MNR) Q2 Earnings and Revenues Beat Estimates

Mach Natural Resources LP (MNR) Q2 Earnings and Revenues Beat Estimates

Mach Natural Resources LP (MNR) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.34 per share. This compares to earnings of $0.76 per share a year ago.

İlgili Semboller 1
MNR MNR
Kaynak: Zacks Investment Research
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: Zacks Investment Research Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Inogen (INGN) Reports Q2 Loss, Tops Revenue Estimates

Inogen (INGN) Reports Q2 Loss, Tops Revenue Estimates

Inogen (INGN) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.15 per share a year ago.

İlgili Semboller 1
INGN INGN
Kaynak: Zacks Investment Research
Kaynağı Ziyaret Et
Yorum Yap